Non-interventional study to evaluate Arimidex in postmenopausal women with advanced breast cancer
Study identifier:NIS-ARO-HCH-2006/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
ARIMIDEX Study ( Non-interventional study to evaluate Arimidex in adjuvant therapy in partial or complete response or stabilized disease after first line chemotherapy in postmenopausal women with advanced breast cancer)
Medical condition
Advanced breast cancer
Phase
-
Healthy volunteers
No
Study drug
anastrozole
Sex
Female
Actual Enrollment
200
Study type
Observational
Age
N/A
Date
Study Start Date: 01 Dec 2006
Primary Completion Date: -
Study Completion Date: -
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
